GlassScriptPhysician profile
Sanjeeb S Bhandari
NPI 1235629239
$1,747.75
in general payments reported to CMS, 2019-2025
10 companies · $522 in 2025
The $522 reported for 2025 was more than what 93% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $385 · 2024: $716 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,622.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $541.68 | 2023-2025 | Eylea Hd, Eylea |
| Regeneron Pharmaceuticals, INC. | $435.42 | 2023-2025 | Eylea Hd, Eylea |
| Genentech, INC. | $226.08 | 2022-2024 | Vabysmo |
| Abbvie INC. | $124.87 | 2024 | |
| Verona Pharma, INC. | $121.91 | 2025 | Ohtuvayre |
| Astellas Pharma US INC | $119.94 | 2025 | Izervay |
| Apellis Pharmaceuticals, INC. | $83.77 | 2024 | Syfovre |
| Bausch & Lomb Americas INC. | $61.39 | 2023-2024 | Vyzulta, Miebo |
| Alcon Vision LLC | $19.72 | 2024 | Rocklatan |
| Horizon Therapeutics Plc | $12.97 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjeeb Bhandari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.